| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000008321 |
| Receipt No. | R000009536 |
| Official scientific title of the study | Prospective randomized trial for optimizing medical therapy after coronary stenitng |
| Date of disclosure of the study information | 2012/07/03 |
| Last modified on | 2017/02/27 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Prospective randomized trial for optimizing medical therapy after coronary stenitng | |
| Title of the study (Brief title) | Calcium-Beta | |
| Region |
|
|
| Condition | ||
| Condition | Coronary artery disease (CAD) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | The study will test whether calcium channel blockers would provide equal or additional benefit compared to standard beta-blocker therapy in Japanese patients who underwent stenting of single vessel lesion. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Presence of Acetylcholine induced coronary vasospasm 9 month after PCI |
| Key secondary outcomes | All cause death
MACEE: acute myocardial infarction, stable or unstable angina, any coronary revascularization procedure, or cerebrovascular accident |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | calcium channel blockers (CCBs) | |
| Interventions/Control_2 | Beta blockers | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients with stable/unstable angina or silent ischemia who underwent PCI with everolimus eluting stent.
2.Single vessel disease with deployment of 3 stents or less. 3.Patients must be 20 years of age or more. |
|||
| Key exclusion criteria | 1.Stent restenosis or previous bypass surgery.
2.Previous diagnosis of vasospasmic angina within 1 years and/or on treatment. 3.Previous PCI within 1 years. 4.An event of acute myocardial infarction within 7 days. 5.Left main disease. 6.Left ventricular ejection fraction of less than 35%. 7.Previous Pacemaker Implant or AV block of more than 1st degree. 8.SBP less than 100 or HR less than 60 prior to PCI. 9.Renal failure (Cr more than 2.0mg/dl or on hemodialysis) 10.Liver failure (eg. cirrhosis) 11.Reversible obstructive lung disease 12.Diagnosis of malignancy within 5 years 13.Pregnancy |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Shun Kohsaka |
| Organization | Keio University, School of Medicine |
| Division name | Division of Cardiology |
| Address | 35 Shinanomachi Shinjuku Tokyo Japan 160-8582 |
| TEL | 03-3353-1211 |
| sk@keio.jp | |
| Public contact | |
| Name of contact person | Shun Kohsaka |
| Organization | Keio University, School of Medicine |
| Division name | Division of Cardiology |
| Address | 35 Shinanomachi Shinjuku Tokyo Japan 160-8582 |
| TEL | 03-3353-1211 |
| Homepage URL | |
| sk@keio.jp | |
| Sponsor | |
| Institute | Keio University, School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Pfizer Japan Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | JAPAN |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009536 |